Thrombin Market to Exhibit CAGR of 4.1% Despite Limited Product Innovations | Fortune Business Insights

The Global Thrombin Market was valued at US$ 535.0 Mn and the forecasted CAGR means that this market will be valued at around US$ 738.7 Mn by the end of 2025. . Thrombin inhibitors play a major part in delaying blood clotting.

Pune, India - May 16, 2019 /MarketersMedia/ —

The Global Thrombin Market is favored by the rising incidence of thrombosis among people, globally. The fatal nature of thrombosis and use of thrombin to trump thrombosis is emphasized in Fortune Business Insights’ latest report, titled “Thrombin Market: Global Analysis, Insights and Forecasts, 2019-2026.” In the report, Fortune Business Insights has briefed that an increasing emphasis on clinical trials of thrombin has boosted the global market and it is estimated to expand at a CAGR of 4.1%. As of 2018, the global thrombin market was valued at US$ 535.0 Mn and the forecasted CAGR means that this market will be valued at around US$ 738.7 Mn by the end of 2025.

Thrombosis can be caused due to mere sedentary lifestyle habits such as smoking and some other factors such as heart failures, aging, and cancer. Thrombin inhibitors play a major part in delaying blood clotting. The healing properties of thrombin, along with its ability to minimize bleeding during surgical procedures has led to an increase in demand for thrombin over the years.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/thrombin-market-100170

Widespread Applications of Thrombin to Boost Global Market

Thrombin has come a long way from its conventional use to stop bleeding in small cuts on body parts. Now, thrombin plays a major role in most of the surgeries, worldwide. The clinical efficiency of thrombin has led to its widespread use in the healthcare industry, a key factor enabling growth in the global thrombin market. Thrombin is vastly effective in facilitating surgical hemostasis. Over the years, human thrombin was replaced with bovine thrombin, due to its increased efficiency in surgical procedures.

Bovine-derived thrombin was successfully used in patients with hemodialysis. Bovine thrombin is massively helpful in treating hemorrhages in hemodialysis, wherein an excessive amount of blood is lost. The extent of blood losses in hemodialysis can lead to various disorders and may also prove fatal in some cases. Thus, bovine-derived thrombin is given huge emphasis and healthcare professionals have prioritized thrombin for treating hemorrhages. The thrombin market is therefore forecast to witness a high demand for bovine-derived thrombin in the com9ing years.

Recothrom to Emerge as The Most Widely Used Product Type

As surgical blood loss has been prioritized by surgeons and healthcare professionals worldwide, there is an increasing need for an efficient solution to minimize such severe losses. Recothrom was initially manufactured by a US-based company, ZymoGenetics. After involvement from Bayer Healthcare, Recothrom was later acquired by Baxter International. The 2018 acquisition of Recothrom by Baxter has proved fruitful to the overall market. As of now, Recothrom is the only drug that has been clinically approved for commercial use as a recombinant thrombin brand. Furthermore, Recothrom finds applications in cases where standard surgical procedures such as suture or cautery are ineffective.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/thrombin-market-100170

Besides Baxter, there have been significant activities from other companies that have contributed to the growth of the global thrombin market. Attractive business strategies of companies such as Pfizer have had a positive impact on the overall market. Pfizer’s has emerged as the leading company, backed by high clinical efficiency of its product ‘Thrombin JMI’. Some other companies that are operating in the global thrombin market are Johnson & Johnson Services Inc., Shanghai RAAS Blood Products Co. Ltd., Japan Blood Products Organization, and Mochida Pharmaceutical Co.

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: +1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/thrombin-market-to-exhibit-cagr-of-41-despite-limited-product-innovations-fortune-business-insights/513505

Source: MarketersMedia

Release ID: 513505

Pakistani waiter finds fame as 'Game of Thrones' look-alike

May 24, 2019

RAWALPINDI, Pakistan — Until recently, a Pakistani waiter working in a small cafe in the city of Rawalpindi knew nothing about the TV series "Game of Thrones" — or its antihero character played by U.S. actor Peter Dinklage. But now, 26-year-old Rozi Khan has customers asking to have selfies taken with him and fields constant questions about his uncanny resemblance to Dinklage, 49. The American actor has played Tyrion Lannister, a witty and wily nobleman, since the series began in 2011. People even stop Khan on the streets, he says, also for selfies. Khan does not only have a similar...

Iraqi TV drama back after 7 years, just in time for Ramadan

May 24, 2019

BAGHDAD — Every evening at the Muntada al-Masrah theater on Baghdad's Rashid street, the cast and crew of the first TV drama filmed in Iraq in seven years take their places among the rooms and courtyard of this 19th-century building and shoot new scenes of their highly-anticipated series. The arts are coming to life again in Baghdad, bringing with it a touch of hope and comfort as the country works to rebuild after 16 years of war. And after two decades abroad, two of Iraq's leading actors have returned to take part in "The Hotel," the twenty-episode drama set to...

Memory center takes visitors through 4 decades of Afghan war

May 24, 2019

KABUL, Afghanistan — A teary-eyed Hameed Rafi said he'll never forget the day he joined a panel of civilian war victims and family members and spoke about the suicide bombing in Kabul that killed his sister last August. Sharing his story with them in March at the Afghanistan Center for Memory and Dialogue, Rafi recalled how all of the wounded in the attack had been taken to hospitals, so he began searching lists of wounded hanging on hospital walls. But he couldn't find the name of his sister, 18-year-old Rahila, who had been studying in an education center for her...

Saudi Arabia beheads 37 for terrorism crimes; most Shiites

May 24, 2019

DUBAI, United Arab Emirates — Saudi Arabia on Tuesday beheaded 37 Saudi citizens, most of them minority Shiites, in a mass execution across the country for alleged terrorism-related crimes. It also publicly pinned the executed body and severed head of a convicted Sunni extremist to a pole as a warning to others. The executions were likely to stoke further regional and sectarian tensions between rivals Saudi Arabia and Iran. Saudi dissident Ali Al-Ahmed, who runs the Gulf Institute in Washington, identified 34 of those executed as Shiites based on the names announced by the Interior Ministry. "This is the largest...

India stops release of biopic on PM Modi ahead of polls

May 24, 2019

NEW DELHI — Indian election authorities have stopped the release of a Bollywood biopic on Prime Minister Narendra Modi with national elections scheduled to begin on Thursday. The Election Commission accepted arguments from the Congress party and other opposition parties that the release of the film, "PM Narendra Modi," would give an unfair advantage to Modi's Hindu nationalist party as it seeks re-election. Film producer Sandip Ssingh had scheduled the release of the movie in Indian theaters for Thursday. The commission ruled Wednesday that any biopic material that has the potential to create an uneven playing field during the multi-phase...

About Us

Get all the up-to-date breaking news about politics, business, entertainment, sports, lifestyles, weather, traffic, and local news in a seamless digital environment only in Morning Dispatcher.

Contact us: sales[at]morningdispatcher.com

Subscribe Now!

Quick Links

HomePress